CRISPR Therapeutics AG (CRSP) Goodwill & Intangibles (2015 - 2024)
CRISPR Therapeutics AG (CRSP) reported Goodwill & Intangibles of $2000.0 for Q1 2024, down 96.49% on a YoY basis from $57000.0 in Q2 2023, and down 87.5% sequentially from $16000.0 in Q4 2023.
CRISPR Therapeutics AG (CRSP) Goodwill & Intangibles (2015 - 2024) Analysis & Trends
CRISPR Therapeutics AG (CRSP) has 10 years of Goodwill & Intangibles data on file, last reported at $2000.0 in Q1 2024.
- For the quarter ending Q1 2024, Goodwill & Intangibles fell 96.49% year-over-year to $2000.0; the trailing twelve-month figure through Mar 2024 stood at $2000.0 (down 96.49% YoY), and the FY2023 full-year result was $16000.0, down 77.46% from the prior year.
- Goodwill & Intangibles fell to $2000.0 in Q1 2024, from $16000.0 in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $221000.0 in Q1 2020 to a low of $2000.0 in Q1 2024.
- A 5-year average of $111764.7 and a median of $112000.0 in 2022 frame the typical range for Goodwill & Intangibles.
- Across the five-year window, Goodwill & Intangibles decreased 19.93% in 2020 and tumbled 96.49% in 2024, its largest moves.
- Tracing CRSP's Goodwill & Intangibles over 5 years: stood at $180000.0 in 2020, then tumbled by 30.56% to $125000.0 in 2021, then plunged by 43.2% to $71000.0 in 2022, then tumbled by 77.46% to $16000.0 in 2023, then plunged by 87.5% to $2000.0 in 2024.
- Business Quant data shows CRSP's Goodwill & Intangibles at $2000.0 in Q1 2024, $16000.0 in Q4 2023, and $30000.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | CRISPR Therapeutics AG | 4.51 Bn | 4.51 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 2,000.00 |
| Dec 31, 2023 | 16,000.00 |
| Sep 30, 2023 | 30,000.00 |
| Jun 30, 2023 | 43,000.00 |
| Mar 31, 2023 | 57,000.00 |
| Dec 31, 2022 | 71,000.00 |
| Sep 30, 2022 | 84,000.00 |
| Jun 30, 2022 | 98,000.00 |
| Mar 31, 2022 | 112,000.00 |
| Dec 31, 2021 | 125,000.00 |
| Sep 30, 2021 | 139,000.00 |
| Jun 30, 2021 | 153,000.00 |
| Mar 31, 2021 | 167,000.00 |
| Dec 31, 2020 | 180,000.00 |
| Sep 30, 2020 | 194,000.00 |
| Jun 30, 2020 | 208,000.00 |
| Mar 31, 2020 | 221,000.00 |
| Dec 31, 2019 | 235,000.00 |
| Sep 30, 2019 | 249,000.00 |
| Jun 30, 2019 | 262,000.00 |